Activation of tumor-associated macrophages by thymosin alpha-1

International Journal of Immunopathology and Pharmacology

Volumn 17, Issue 1, 2004, Pages 39-47

  Shrivastava, P ^a   Singh, Sukh Mahendra ^a   Singh, N ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Dalton's lymphoma; Thymosin 1; Tumor associated macrophages

Indexed keywords

DALTON LYMPHOMA; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; THYMOSIN ALPHA1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; DRUG DERIVATIVE; GROWTH INHIBITOR; THYMOSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; IN VITRO STUDY; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION INHIBITION; MOUSE; MOUSE STRAIN; NONHUMAN; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; T CELL LYMPHOMA; THYMUS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL DESTRUCTION; ANIMAL; ANTIGEN PRESENTING CELL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG SCREENING; FEMALE; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; PERITONEUM MACROPHAGE;

ANIMALS; ANTIGEN-PRESENTING CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; GROWTH INHIBITORS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-1; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE; PHAGOCYTOSIS; PINOCYTOSIS; REACTIVE OXYGEN SPECIES; THYMOSIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 5444248748     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200401700106     Document Type: Article

References (39)

1. Adams D.O. and T.A. Hamilton. 1984. The cell biology of macrophage activation. Ann. Rev. Immunol. 2:283.
2. Evans R. and S. Haskill. 1983. The reticuloendothelial system: Comprehensive treaties. Int. Cancer. 5:155.
3. Foss F.M. 2002. Immunologic mechanism of antitumor activity. Semin. Oncol. 3:5
4. Bingle C., N.J. Brown and C.E. Lewis. 2002. The role of tumor associated macrophages in tumor progression implications of new anticancer therapies. J. Pathol. 196:254.
5. Chu C.S., F.Y. Woo, A.J. Toll, S.C. Rubin, C.H. June, R.G. Caroll and K. Schlenger. 2002. Tumor associated macrophages as a source of functional dendritic cells in ovarian cancer patients. Clin. Immunol. 102:291.
6. Mantovani A., B. Bottazzi, S. Sozzani, F. Colotta and L. Ruco. 1992 Origin and function of tumor associated macrophages. Immunol. Today 13:265.
7. Hannigan B.M., O.R. Mcnally, O. Kirrane and S.J. Eason. 1992. Tumor cell inhibition of macrophage cytokine activity. FEMS. Microbiol. Immunol. 105:283
8. Mantovani A., B. Bottazzi, S. Sozzani, G. Peri, P. Allavena, G. Gangdong, A. Vicchi and F. Colotta. 1993. Cytokine regulation of tumor associated macrophages. Res. Immunol. 144:280.
9. Ben-effraim. S. 1999. One hundred years of cancer Immunotherapy: A critical appraisal. Tumor Biol. 20:1.
10. Parajuli P. and S.M. Singh. 1996. Alteration in IL-1 and arginase activity of tumor-associated macrophage: a role in the promotion of tumor growth. Cancer Lett. 107:249.
11. Parajuli P., S.M. Singh, A. Kumar and A. Sodhi. 1997. Alterations in the tumoricidal functions of murine tumor associated macrophages during progressive growth of tumor in vivo. Cancer J. 10:222.
12. Baumann C., M. Badamachian and A.L. Goldstein. 1997. Preclinical studies of thymosinal and thymosin β4. In Thymic peptides in Preclinical and clinical medicine and update, ed. H.R. Maurer, A.L. Goldstein, E.D. Hager. W. Zuckschwerdt Verlag Munchen, p.13.
13. Garaci E., F. Pica, G. Rasi and C. Favalli. 2000 Thymosinα1 in the treatment of cancer from basic research to clinical application. Int. J. Immunopharmacol. 22:1067.
14. Garbin F., K. Eckert, P. Buttner, C. Garbe and H.R. Maurer. 1995. The influence of thymic preparation thymex-L on deficient antitumor activity of monocytes from melanoma patients in vitro. Oncol. Rep. 2:469.
15. Kullavanuaya P., S. Treeprasertsuk, B. Thongngam, K. Chaermathi and P. Suwanagool. 2001. The combined treatment of Interferon alpha-2a and thymosinα1 for chronic hepatitis C: The 48 weeks of treatment result. J. Med. Assoc. Thai. 84:5462.
16. Ohmori H., M. Kamo, K. Yamakoshi, M.H. Nitta, M. Hikida and N. Kanayama. 2001. Restoration of immunocyte function by thymosinα1 in cyclophosphamide induced immunodeficient mice. Immunopharmacol. Immunotoxicol. 23:75.
17. Roy R., S.M. Singh and A. Shanker. 2000. Mechanism of thymocyte apoptosis induced by serum of tumor-bearing host: the molecular events involved and their inhibition by thymosinal. Int. J. Immunopharmacol. 22:309.
18. Ancell C.D., J. Phipps and L. Young. 2001. Thymosin alpha-1. Am. J. Health. Syst. Pharm. 15:879.
19. Billich A. 2002. Thymosin alpha1. Curr.Opin.Investig. Drugs 3:698
20. + thymocytes. Tumor Biol. 21:288.
21. Shanker A., S.M. Singh and A. Sodhi. 2000. Ascitic growth of a spontaneous transplantable T cell lymphoma induces thymic involution 2. Induction of apoptosis in thymocytes. Tumor Biol. 21:315.
22. Shanker A., S.M. Singh and A. Sodhi. 2000. Impairment of T cell function with the progressive ascitic growth of transplantable T cell lymphoma of spontaneous origin. FEMS Immunol. Med. Microbial. 27:247.
23. Bodey B., B. Jr. Bodey, S.E. Sigel and H.E. Kaiser. 2000. Review of thymic hormones in cancer diagnosis and treatment. Int. Immunopharmacol. 22:261.
24. Eckert K., F. Garbin, E. Grunberg and H.R. Maurer. 1997. Prothymosinα1: Preclinical studies with immune cells from cancer patients. In Thymic peptides in Preclinical and clinical medicine and update. ed. W. Zuckschwerdt Verlag Munchen, p. VII.
25. Eckert K., G. Mayer, R. Stange, M. Kalden, K. Krasagakis and H.R. Maurer. 1997. Effect of thymic peptides, in vitro, on the impaired immunocytotoxicity of peripheral blood mononuclear cells from tumor patients. Int. J. Oncol. 10:481.
26. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Meth. 65:55.
27. Kumar A. and S.M. Singh. 1995. Effect of Dalton's lymphoma on as antigen presentation of murine peritoneal macrophages. Cancer Lett. 92:151.
28. Oda T. and H.A. Maeda. 1986. New simple fluorometric assay for phagocytosis. J. Immunol. Methods. 17:175.
29. Kumar A., S.M. Singh and P. Parajuli. 1994. Modulatory effects of Dalton's Lymphoma cells on the production of reactive nitrogen intermediates, IL-1 and TNF by murine peritoneal macrophages. Neoplasma 44:363.
30. Gupta P. and A. Sodhi. 1988. Study on pinocytosis and antigen presentation by murine peritoneal macrophages to T-cell in vitro after cisplatin treatment. Archivum Immunol. Ther. Exp. 36:315.
31. 2 and lysozyme from human monocytes in vitro. Ind. J. Exp. Biol. 29:910.
32. Kumar A., P. Parajuali and S.M. Singh. 1996. Gangliosides produced by a T cell lymphoma inhibit the production of reactive nitrogen intermediates by murine peritoneal macrophages. J. Clin. Biochem. Nutr. 21:171.
33. Alleva D.G., C.J. Burger and K.D. Elgert. 1994. Tumor induced regulation of suppressor macrophage nitric oxide and TNFα Production: role of tumor derived IL-10, TGF-β, and Prostaglandin E2. J. Immunol. 153:1674.
34. Rinaldi-Garaci C., E. Garaci, V. Del Gobbo, C. Favalli, T. Jezzi and A.L. Goldestin. 1983. Modulation of endogenous prostaglandin by thymosinal in lymphocytes. Cell. Immunol. 80:57.
35. Shanker A. and S.M. Singh. 2003. Immunopotentiation in mice bearing a transplantable T-cell lymphoma: role of thymic extract. Neoplasma (in press).
36. Philip R. and L.B. Epestein. 1986. Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γinterferon and interleukin-1. Nature 323:86.
37. Onozaki K., K. Matsushima, B.B. Aggrawl and J.J. Oppenheim. 1985. Human IL-1 is a cytocidal factor for several tumor cell lines. J. Immunol. 135:3962.
38. G. Mazzoccoli, M. Grilli, S. Carughi, F. Puzzolante, A. De Cata, M. La Viola, A. Giuliani, N. Urbano, R. Tarquini and F. Perfetto. 2003. Immune system alterations in lung cancer patients. Int. J. Immunopathol. Pharmacol. 16:167.
39. Garaci C., M.R. Torrisi, T. Jezzi, L. Frati, A.L. Goldstein. and E. Garaci. 1985. Receptors for Thymosinα1 on mouse thymocytes. Cell. Immunol. 91:289.